Mark For: ION™ trademark registration is intended to cover the categories of genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; medical testing and diagnostic services, namely, diagnostic testing, monitoring, tracking, and reporting for detecting minimal residual disease (MRD) by analyzing, testing, tracking, and reporting DNA, genomes, genotype, and genetic mutations using whole genome pattern recognition, low-input liquid blood biopsy, aggregated SNC and CNV signals, and tracking tumor progression as it evolves during the patient treatment and follow up period.
Status
2021-12-14 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Medical, beauty & agricultural) Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Todd Braverman, Esq.
Attorney Docket Number
T-611216-US
Timeline
2021-12-09
Application Filed
2021-12-13
Location: NEW APPLICATION PROCESSING
2021-12-13
Status: Live/Pending
2021-12-13
Status: New application will be assigned to an examining attorney approximately 6 months after filing date.
TODD BRAVERMAN, ESQ. PEARL COHEN ZEDEK LATZER BARATZ LLP TIMES SQUARE TOWER, 7 TIMES SQUARE 19TH FLOOR NEW YORK, NY 10036
Good, Services, and Codes
International Codes:
44
U.S. Codes:
100,101
Type Code
Type
GS0441
Genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; medical testing and diagnostic services, namely, diagnostic testing, monitoring, tracking, and reporting for detecting minimal residual disease (MRD) by analyzing, testing, tracking, and reporting DNA, genomes, genotype, and genetic mutations using whole genome pattern recognition, low-input liquid blood biopsy, aggregated SNC and CNV signals, and tracking tumor progression as it evolves during the patient treatment and follow up period
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
OneLook
Acronym Finder
C2i Genomics, Inc.
Application
| 